| Oct 31 |
Cybin to Participate at the 2024 Milken Institute Future of Health Summit
|
| Oct 24 |
Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
|
| Oct 15 |
Cybin: Top Value Psychedelic Stock
|
| Oct 3 |
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
|
| Oct 1 |
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
|
| Sep 24 |
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
|
| Sep 19 |
Cybin Provides Corporate Update on Upcoming Clinical Milestones
|
| Sep 19 |
'We're Pretty Cheap At The Moment' - Cybin CEO Doug Drysdale
|
| Sep 19 |
Cybin Announces Completion of Previously Announced Share Consolidation
|
| Sep 15 |
Wall Street Breakfast: The Week Ahead
|
